Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Mezzanine Equity and Shareholders??? Equity

v3.24.1
Consolidated Statements of Mezzanine Equity and Shareholders’ Equity - USD ($)
$ in Thousands
Warrants To Placement Agent
Redeemable Convertible Preferred Stock
Common Stock
Non-voting Common Stock
Additional paid-in capital
Accumulated deficit
Total
Balance at Dec. 31, 2021 $ 5,585 [1] [1] $ 2,824 $ (22,420) $ (19,596)
Balance (in Shares) at Dec. 31, 2021 [2]   773,108 205,040 178,377      
Exercise of options into common stock [1] [1] 5 $ 5
Exercise of options into common stock (in Shares)     77,749 [2]       7,775
Reclassification of warrants from liabilities to equity (see note (14(d))            
Share based compensation [1] [1] 220 220
Conversion of convertible redeemable preferred stock to common stock upon initial public offering $ (5,585) $ 1 [1] [1] 5,584 5,585
Conversion of convertible redeemable preferred stock to common stock upon initial public offering (in Shares) [2]   (773,108) 773,108        
Issuance of common stock upon initial public offering and private placement, net of underwriting discounts and commissions and other offering costs [1] [1] 14,675 14,675
Issuance of common stock upon initial public offering and private placement, net of underwriting discounts and commissions and other offering costs (in Shares) [2]     421,250        
Conversion of convertible loan to common stock upon initial public offering [1] [1] 6,553 6,553
Conversion of convertible loan to common stock upon initial public offering (in Shares) [2]     163,816        
Conversion of convertible note to common stock upon initial public offering [1] [1] 3,600 3,600
Conversion of convertible note to common stock upon initial public offering (in Shares) [2]     90,009        
Conversion of warrants to common stock upon initial public offering [1] [1] 3,190 3,190
Conversion of warrants to common stock upon initial public offering (in Shares) [2]     79,756        
Redemption of non-voting common stock upon initial public offering [1] [1] [1]
Redemption of non-voting common stock upon initial public offering (in Shares) [2]       (178,377)      
Repurchase of common stock [1] [1] 15 15
Repurchase of common stock (in Shares) [2]     (2,700)        
Net loss [1] (10,982) (10,982)
Balance at Dec. 31, 2022 $ 1 [1] [1] 36,666 (33,402) $ 3,265 [3]
Balance (in Shares) at Dec. 31, 2022   [2] 1,737,986 [2] [2]     1,737,986 [3]
Exercise of options into common stock [1] [1]
Exercise of options into common stock (in Shares)     32,009 [2]       2,489
Issuance of common stock and pre-funded warrants upon private placement, net of underwriting commissions and other offering costs 159 [1] [1] 2,609 $ 2,609
Issuance of common stock and pre-funded warrants upon private placement, net of underwriting commissions and other offering costs (in Shares) [2]     491,000        
Exercise of pre-funded warrants into common stock [1] [1] [1] [1]
Exercise of pre-funded warrants into common stock (in Shares) [2]     754,670        
Reclassification of warrants from liabilities to equity (see note (14(d)) [1] [1] 314   314
Share based compensation [1] [1] 377 377
Repurchase of common stock [1] [1] (50) (50)
Repurchase of common stock (in Shares) [2]     (7,920)        
Net loss [1] [1] (6,286) (6,286)
Balance at Dec. 31, 2023 $ 159 $ 1 [1] [1] $ 39,916 $ (39,688) $ 229 [3]
Balance (in Shares) at Dec. 31, 2023   [2] 3,007,745 [2] [2]     3,007,745 [3]
[1] Represents an amount less than $1 thousand.
[2] Adjusted to reflect reverse stock split, see note 2(ff).
[3] Adjusted to reflect reverse stock split, see note 2(ff).